Venture Map · Round
DeepUll — Series B · €13M
Announced 2022-10-20 · Barcelona · Medtech / Diagnostics
DeepUll develops culture-free diagnostics for early sepsis detection. It raised a €13M Series B led by Innvierte (CDTI) together with an undisclosed strategic investor, with existing investors Kurma Partners, Alta Life Sciences, UI Investissement and Axis also taking part. Sabadell Asabys later extended the round to €17M.
RoundSeries B
Amount€13M
LeadCDTI Innvierte
Date2022-10-20
CityBarcelona
SectorMedtech / Diagnostics
